The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies

scientific article (publication date: August 2007)

The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies is …
instance of (P31):
systematic reviewQ1504425
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.3324/HAEMATOL.10234
P698PubMed publication ID17650440
P5875ResearchGate publication ID6189148

P2093author name stringMartin H Prins
Paolo Prandoni
Antonio Marchiori
Laura Mosena
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectFactor V LeidenQ185986
systematic reviewQ1504425
Prothrombin G20210AQ2113626
heterozygosityQ124059385
venous thromboembolismQ9397786
P304page(s)1107-14
P577publication date2007-08-01
P1433published inHaematologicaQ5638209
P1476titleThe risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies
P478volume92

Reverse relations

cites work (P2860)
Q47440459Are Prothrombotic Mutations a Time-to-Event Risk Factor?
Q26796430Assessing the risk of recurrent venous thromboembolism--a practical approach
Q37207947Cerebropulmonary dysgenetic syndrome
Q45877007Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders.
Q90452318Coagulation, Microenvironment and Liver Fibrosis
Q43577809Contribution of recurrent venous thrombosis and inherited thrombophilia to the pathogenesis of postthrombotic syndrome
Q57643254Diagnosis of uterine vein thrombosis on transvaginal ultrasound
Q46542845Diffuse cerebral infarct associated with factor V Leiden and prothrombin 20210A mutations in a patient with tetralogy of Fallot
Q35112558Effect of Platelet Glycoprotein IIb/IIIa PLA2 Polymorphism on Severity of Pulmonary Thromboembolism
Q38385253Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™.
Q38881922Electronic health record interventions at the point of care improve documentation of care processes and decrease orders for genetic tests commonly ordered by nongeneticists.
Q38986410Environmental and Genetic Risk Factors Associated with Venous Thromboembolism
Q45941946Evaluation of the Nanosphere Verigene System and the Verigene F5/F2/MTHFR Nucleic Acid Tests.
Q37641282Factor V Leiden and activated protein C resistance
Q34152374Factor V Leiden thrombophilia
Q36045799Factor V-Leiden Mutation: A Common Risk Factor for Venous Thrombosis among Lebanese Patients
Q40307133Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia
Q37396981Genetics and the general physician: insights, applications and future challenges
Q89002092Hypercoagulable States and Thrombophilias: Risks Relating to Recurrent Venous Thromboembolism
Q43233746Inactivation of thrombomodulin by ionizing radiation in a cell-free system: possible implications for radiation responses in vascular endothelium
Q33904210Influence of acquired and genetic risk factors on the prevention, management, and treatment of thromboembolic disease
Q38178063Inherited risk factors for venous thromboembolism
Q41124495Isolated thrombosis of right spermatic vein with underlying Factor V Leiden mutation
Q48297715Kallmann syndrome patient with gender dysphoria, multiple sclerosis, and thrombophilia
Q46490008MTHFR C677TT, PAI1 4G-4G, V Leiden Q506, and prothrombin G20210A in hepatocellular carcinoma with and without portal vein thrombosis
Q36718482Management of patients with unprovoked venous thromboembolism: an evidence-based and practical approach
Q58689588Pathophysiology of Post-Thrombotic Syndrome: The Effect of Recurrent Venous Thrombosis and Inherited Thrombophilia
Q51047838PlA2 Polymorphism in Glycoprotein IIb/IIIa Modulates the Morphology and Nanomechanics of Platelets.
Q46047297Prothrombotic gene mutations in patients with sudden sensorineural hearing loss and cardiovascular thrombotic disease
Q38283515Recurrent venous thromboembolism in a patient with heterozygous factor v leiden mutation
Q30244631Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China
Q34153343Risk assessment for recurrent venous thrombosis
Q40135109Rs5918ITGB3 Polymorphism, Smoking, and BMI as Risk Factors for Early Onset and Recurrence of DVT in Young Women
Q38250865The real value of thrombophilia markers in identifying patients at high risk of venous thromboembolism
Q44247861Thrombophilia differences in splanchnic vein thrombosis and lower extremity deep venous thrombosis in North America
Q37892665Using the laboratory to predict recurrent venous thrombosis
Q33573008Variants of a Thermus aquaticus DNA polymerase with increased selectivity for applications in allele- and methylation-specific amplification.
Q41496563Variants of sequence family B Thermococcus kodakaraensis DNA polymerase with increased mismatch extension selectivity
Q38117733Venous thrombosis: understanding the paradoxes of recurrence
Q82993880[Follow-up of pulmonary thromboembolism]

Search more.